it is my understanding that this announcement from NCCN which is only guidelines ... is in fact neutral for TLX
at moment TLX cannot market Illuccix for patient selection but a customer could choose it and still claim reimbursement
im thinking the NCCN guidelines suggest all of the manufacturers can now be selected . novartis has issues currently and Lantheus is more difficult to have delivered on time every time ???
i wont really comment on the stock price, albeit disappointing
at some point, if you are a believer, you buy the business and walk away
- Forums
- ASX - By Stock
- Approval
it is my understanding that this announcement from NCCN which is...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$19.13 |
Change
-0.340(1.75%) |
Mkt cap ! $6.401B |
Open | High | Low | Value | Volume |
$19.41 | $19.46 | $18.81 | $121.0M | 6.335M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7316 | $19.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.13 | 6814 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12500 | 18.990 |
1 | 1000 | 18.950 |
1 | 3 | 18.910 |
4 | 1715 | 18.900 |
1 | 2000 | 18.890 |
Price($) | Vol. | No. |
---|---|---|
19.370 | 1500 | 1 |
19.450 | 50 | 1 |
19.470 | 500 | 1 |
19.480 | 45 | 1 |
19.490 | 53 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |